Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-25-020311
Filing Date
2025-04-28
Accepted
2025-04-28 16:32:46
Documents
21
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A aadi-20250428.htm   iXBRL DEF 14A 602104
6 aadi-20250428_g1.jpg GRAPHIC 19598
7 aadi-20250428_g2.gif GRAPHIC 217795
8 aadi-20250428_g3.gif GRAPHIC 110956
9 aadi-20250428_g4.jpg GRAPHIC 475830
10 aadi-20250428_g5.jpg GRAPHIC 259579
  Complete submission text file 0001628280-25-020311.txt   3837772

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aadi-20250428.xsd EX-101.SCH 2996
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aadi-20250428_def.xml EX-101.DEF 3396
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aadi-20250428_lab.xml EX-101.LAB 3906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aadi-20250428_pre.xml EX-101.PRE 2429
23 EXTRACTED XBRL INSTANCE DOCUMENT aadi-20250428_htm.xml XML 98573
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 25880909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)